TrialOncotarget2014

Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study.

Isamu Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.